In this episode of SurgOnc Today, live from SSO 2024, Dr. Alex Parikh from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, are joined by Dr. Ana Gleisner from the University of Colorado and Dr. Skye Mayo from the Oregon Health and Sciences University. They will be discussing two important aspects of the surgical management of perihilar...

In this episode of SurgOnc Today®, Sonia Orcutt, MD and Michail Mavros, MD, from the University of Arkansas for Medical Sciences are joined by Callisia N. Clarke, MD, MS, FACS, FSSO, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin, and Alexandra Gangi, MD, FSSO, Director of the Gastrointestinal Tumor Program at Cedars Sinai Medical Center. The optimal treatment of high-grade well-differentiated neuroendocrine tumors has not been well-described, as they have only...

In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and...

In this episode of SurgOnc Today®, Jennifer Plichta MD, Associate Professor of Surgery and Director of the Breast Risk Assessment Clinic at the Duke University Medical Center, is joined by Melissa Pilewskie, MD, Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan and Zahraa AlHilli, MD, MBA, Interim Director of the Breast Center and Co-Director of the Comprehensive Breast Program at Cleveland Clinic. Given the continuous advancements in breast...

The management of locally advanced extremity soft tissue sarcomas require a multidisciplinary approach. Surgery remains the standard of care for cure, however, other loco-regional treatments including radiation and isolated limb perfusion as well as systemic treatments have been utilized to reduce local and distant recurrence risk. In this podcast, we will focus on the multidisciplinary approach for locally advanced extremity sarcomas. We will highlight the role of limb-sparing resections...

In this episode of SurgOnc Today®, Gautam Malhotra, MD, interviews Jeremy L. Davis, MD, Mio Kitano, MD, and Sonia Orcutt, MD, live at SSO 20204 after their panel discussion on “Getting the Most out of ERAS Pathways for Patients Undergoing Gastric Cancer Surgery”. They review the current literature on the use of ERAS for gastric cancer surgery, the importance of multi-disciplinary approach, and the challenges in the implementation.

This episode of SurgOnc Today®, recorded at SSO 2024, focuses on understanding the training and preparation needed prior to embarking on pelvic exenterative surgery and international collaboration to improve the outcomes of complex pelvic resections.

In this episode of SurgOnc Today, Sarah McLaughlin, MD, interviews renowned surgical oncologists Lisa Newman, MD, MPH, and Monica Morrow, MD, to get their perspectives on how women’s experiences with medical school, surgical training, and professional career trajectories have evolved during their time in medicine.

In this episode for SurgOnc Today, Jeffrey Farma, MD, from Fox Chase Cancer Center/Temple Health in Philadelphia, PA, interviews James Jakub, MD, from Mayo Clinic Jacksonville, FL and Luke Rothermel, MD, MPH, from University Hospitals-Cleveland Medical Center Cleveland, OH.  We will review the current updates on the evaluation, workup and treatment of patients with Merkel cell carcinoma.  This will include the surgical management, current trends on both neoadjuvant and adjuvant therapy,...

In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies,...

In this episode of SurgOnc Today®, join us as the Women in Cancer Surgery working group shares their triumphs, challenges, and the impactful experiences that have shaped their journeys in cancer surgery. Moderated by Sarah McLaughlin, MD, FSSO, and featuring Margo Shoup, MD, MBA, FSSO, Nathalie Johnson, MD, and Julie Ann Sosa, MD, MA, FACS, FSSO, explore the unwavering commitment and inspiring stories behind these exceptional women.

ALT/WDLPS are fatty tumors most commonly occurring in the extremity and retroperitoneum that have a relatively indolent behavior, but a strong predilection for local recurrence. In this episode of SurgOnc Today®, Episode 2 of this series on ALT/WDLPS, Brian Kadera, MD, John Mullinax, MD, Giorgos Karakousis, MD, and Steven Thorpe, MD, will focus on local management, surgical approaches, and the risks/benefits of radiation in the neoadjuvant/adjuvant setting. We will highlight differences in...

In this episode of SurgOnc Today®, Tina Hieken, MD, from the Mayo Clinic, in Rochester, Minnesota, interviews Jay Lee, MD, MHSc, from Duke University in Durham, North Carolina, and Julia Terhune, MD, from the University of Maryland in Baltimore, Maryland. They will discuss the current and evolving indications for adjuvant therapy in patients with stage III melanoma including vaccine trials.

Lymph node dissection is a crucial component of the surgical treatment of gastric cancer. The technical aspects of lymph node dissection, especially D2, require a significant degree of training and expertise. In this episode of SurgOnc Today®, Ahmed Dehal, MD, MPH, interviews Vivian Strong, MD, from Memorial Sloan Kettering Cancer Center and Yanghee Woo, MD, from City of Hope to discuss this topic.

In this episode of SurgOnc Today, Associate Professor Gabrielle van Ramshorst MD, PhD, and Dr. Patrick Sullivan, MD, moderate a discussion with two top experts in the field of pelvic exenteration surgery, Dr. Brian Bednardski, MD, and Professor Michael Solomon, MD, PhD, on their experience in this complex type of surgery. The discussion covers the definition of pelvic exenteration, the organization of care, training in pelvic exenteration surgery, and recent developments in this field.

In this episode of SurgOnc Today®, Brian E. Kadera, MD, Ben Hinrichs, MD, and Konstantinos Chouliaras, MD, focus on the diagnosis and work-up of fatty tumors in the extremity and the retroperitoneum. They highlight the imaging features, the utility of biopsy and specifically, MDM2 fluorescence in-situ hybridization. They also review the pitfalls of gross and microscopic margin assessment.

In this episode of SurgOnc Today, Julie Hallet, MD, MSc, Vice-Chair of the SSO HPB disease site working group, and Lavanya Yohanathan, MD, from the HPB disease site working group are joined by Melissa Hogg, MD, from Northshore University Hospital and Giovanni Marchegiani, MD, from the University of Padova. They will discuss two key clinical scenarios during surveillance of pancreatic cystic neoplasms: when to pull the trigger on resection and if or when to discontinue surveillance. Show...

In this episode of SurgOnc Today, Alexander Parikh MD, MPH, FACS, FSSO, will continue the discussion on the nuts and bolts of neoadjuvant therapy for pancreas cancer with Syed Ahmad, MD, and Susan Tsai, MD, MHS. In part 2, they specifically discuss two important aspects of delivering neoadjuvant therapy for pancreatic adenocarcinoma. Specifically, how to choose which specific regimens to use and the role of chemoradiation. 

In this episode of SurgOnc Today®, Genevieve Boland, MD, PhD, Amanda Kirane, MD, and G. Paul Wright, MD, discuss breaking news and updates from the Society of Immunotherapy of Cancer (SITC) and Society of Melanoma Research (SMR) meetings.

In this episode of SurgOnc Today®, Puneet Singh, MD, and Anna Weiss, MD, discuss the newly published SOUND and LUMINA clinical trials. Both trials explore local regional de-escalation, omitting sentinel lymph node biopsy and radiation, respectively. They discuss the treatment challenges that incorporating these trial results may pose with their special guest, Kimberly Corbin, MD.

In this episode of SurgOnc Today®, Samantha Ruff, MD, Rupen Shah, MD, Mustafa Raoof, MD, and Danielle DePeralta, MD, discuss the role of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) and its emerging role in the management of peritoneal surface malignancies. We review the existing literature for this treatment modality and the recently published multi-center phase I trial performed in the United States. 

In this episode of SurgOnc Today®, Mihir M. Shah, MD, Mashaal Dhir, MD, and June S. Peng, MD, discuss the workup and management of gastric adenocarcinoma. The discussion elaborates on several scenarios, including molecular testing, surgical approaches to advanced gastric cancers, treatment sequencing, tumor-related gastric obstruction management, diagnostic laparoscopy role, perioperative management, and low-volume carcinomatosis management.

In this episode of SurgOnc Today®, Michail Mavros, MD, and Sonia T. Orcutt, MD from the University of Arkansas for Medical Sciences are joined by Jonathan R. Strosberg, MD, head of the Neuroendocrine Division in the Department of Gastrointestinal Oncology, Moffitt Cancer Center and Past President of the North American Neuroendocrine Tumor Society (NANETS), and Mary A. Maluccio, MD, MPH, chief of the Division of Surgical Oncology at LSU and medical director of the NET Louisiana program....

This episode of SurgOnc Today®, features guest faculty, Astrid Botty Van Den Bruele, MD, and Meghan Flanagan, MD, MPH. In a contemporary group of patients diagnosed with contralateral axillary metastases (CAM), those selected for treatment with presumed curative intent experienced improved OS when compared to stage IV (M1) patients. The current literature, as well as some forthcoming data, adds additional support for re-evaluating the stage IV designation, in favor of N3, and consideration of...